Evaluate Safety & Efficacy of Condroflex in Subjects With OA
NCT ID: NCT00838487
Last Updated: 2009-10-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
240 participants
INTERVENTIONAL
2009-03-31
2010-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study of Non-inferiority With Participants Diagnosed With Primary Knee OA (GLACIAL)
NCT02830919
Effectiveness of Glucosamine + Chondroitin in Osteoarthrosis
NCT00860873
Study With Chondroitin Sulfate and Glucosamine Sulfate (in Dosage Capsule and Sachet) in Treating Osteoarthritis
NCT01293305
Condrosulf vs Celebrex vs Placebo in the Treatment of Knee OA
NCT02079727
Non-inferiority Study of the Glucosamine Sulfate + Chondroitin Sulfate Association Capsule in Comparison to the CONDROFLEX® Product in Osteoarthrosis of the Knee
NCT01172249
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
condroflex and exercise
assent arm
condroflex and exercise
1 sachet oral once a day by 12 Weeks / therapeutic exercise 3 times a week
sugar pill and exercise
sugar pill arm
sugar pill and exercise
1 sachet oral once a day by 12 Weeks / therapeutic exercise 3 times a week
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
condroflex and exercise
1 sachet oral once a day by 12 Weeks / therapeutic exercise 3 times a week
sugar pill and exercise
1 sachet oral once a day by 12 Weeks / therapeutic exercise 3 times a week
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* to be capable to consent
Exclusion Criteria
* concomitant diseases
* concomitant drugs
40 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zodiac Produtos Farmaceuticos S.A.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Zodiac Produtos Farmaceuticos
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Suely Roizenblatt
Role: PRINCIPAL_INVESTIGATOR
CRM Regional Council of Medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CRDB
São Paulo, , Brazil
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZODIAC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.